CIK 0001781983
- Non-accelerated filer
- Smaller reporting company
Aprea Therapeutics, Inc.
Sign in to watch- Ticker
- APRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 215-948-4119
- Business address
- 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-12 | Gilad Oren President/CEO | Grant or award | +20,175 | 393,895 | ||
| 2026-03-12 | Gilad Oren President/CEO | Grant or award · Stock Options (Right to Buy) | +80,700 | 80,700 | ||
| 2026-01-30 | Gilad Oren President/CEO | Purchase | +28,100 | $0.89 | $25K | 373,720 |
| 2026-01-30 | Gilad Oren President/CEO | Purchase · Common Warrant | +28,100 | 28,100 | ||
| 2025-12-10 | Gilad Oren President/CEO | Purchase · Pre-Funded Warrant | +21,459 | $1.17 | $25K | 21,459 |
| 2025-12-10 | Gilad Oren President/CEO | Purchase · Common Warrants | +21,459 | 21,459 | ||
| 2025-04-03 | Gilad Oren President/CEO | Purchase | +3,003 | $1.87 | $6K | 343,123 |
| 2025-04-03 | Gilad Oren President/CEO | Purchase | +2,497 | $1.80 | $4K | 345,620 |
| 2025-03-27 | Gilad Oren President/CEO | Grant or award | +6,725 | 340,120 | ||
| 2025-03-27 | Gilad Oren President/CEO | Grant or award · Stock Options (Right to Buy) | +26,900 | 26,900 | ||
| 2024-10-23 | Gilad Oren President/CEO | Purchase | +500 | $3.92 | $2K | 333,395 |
| 2024-10-15 | Gilad Oren President/CEO | Purchase | +250 | $2.90 | $725 | 332,895 |
| 2024-10-14 | Gilad Oren President/CEO | Purchase | +1,000 | $2.59 | $3K | 332,645 |
| 2024-10-10 | Gilad Oren President/CEO | Purchase | +150 | $2.54 | $381 | 331,645 |
| 2024-03-28 | Gilad Oren President, CEO | Grant or award | +6,725 | 331,495 | ||
| 2024-03-28 | Gilad Oren President, CEO | Grant or award · Stock Options (Right to Buy) | +26,900 | 26,900 | ||
| 2024-03-13 | Gilad Oren President, CEO | Purchase | +2,000 | $7.29 | $15K | 324,770 |
| 2024-03-13 | Gilad Oren President, CEO | Purchase · Tranche A Warrant | +1,000 | 1,000 | ||
| 2024-03-13 | Gilad Oren President, CEO | Purchase · Tranche B Warrant | +1,000 | 1,000 | ||
| 2023-03-09 | Gilad Oren President, CEO | Grant or award | +4,000 | 322,770 |
Page 1 of 2 · 25 trades